Pharma Journalist -

Supported by Suzhou Government, MDS joins forces with major partners in various medical sectors and together stage the first Global Device Week in Suzhou from 6-9 September 2018 –…
Read More...

The U.S. Food and Drug Administration approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU). Patients with PKU are born…
Read More...

Avara Pharmaceutical Services announced that it has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical…
Read More...

Samsung BioLogics announced that a third monoclonal antibody Drug Substance has been licensed by the US FDA (Food and Drug Administration) for its second plant, the world's largest…
Read More...

SMi Reports: With 2 weeks until the 2nd Annual Pharmaceutical Microbiology West Coast conference, potential attendees are urged to book their place soon, as places are limited. There…
Read More...

Clinigen Group plc has signed an agreement with Nordic Pharma Ltd. to manage the supply and distribution of aprotinin in a range of countries in Asia Pacific and South Africa.…
Read More...

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced that the company achieved an undisclosed milestone payment from…
Read More...

SOTIO, a biotechnology company owned by the PPF Group, announces today that the first patient was enrolled to the SP015 clinical trial of a combination of DCVAC/PCa, an active cellular…
Read More...

Lunaphore Technologies SA, a next generation tissue diagnostics company, and Vitro SA, a manufacturer in the field of Pathology and Biomedical Research, announce today a collaboration…
Read More...

BERG announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the Company's lead product candidate, BPM 31510 (ubidecarenone), for the…
Read More...